Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Maxcyte, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 120 | 1 | 119 | 0 |
| Shares | 68.7M | 38.7K | 72.6M | +3.91M (+5.7%) |
| Value | $267.4M | $150.6K | $301.9M | +$34.7M (+13.0%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Maxcyte, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mirabella Financial Services LLP | 3,700,000 | $15.4M | 1.41% |
| AXA S.A. | 986,897 | $4.11M | 0.01% |
| Rice Hall James & Associates, LLC | 263,833 | $1.10M | 0.06% |
| HRT Financial LP | 126,245 | $525.0K | 0.00% |
| Walleye Capital LLC | 110,891 | $461.3K | 0.00% |
| XTX Topco Ltd | 58,866 | $244.9K | 0.02% |
| EntryPoint Capital, LLC | 44,458 | $184.9K | 0.08% |
| Centiva Capital, LP | 24,993 | $104.0K | 0.00% |
| Graham Capital Management, L.P. | 23,047 | $95.9K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 21,237 | $88.3K | 0.00% |
| Two Sigma Advisers, LP | 17,800 | $74.0K | 0.00% |
| Catalyst Funds Management Pty Ltd | 17,700 | $73.6K | 0.02% |
| Prudential Financial Inc | 15,630 | $65.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 13,518 | $56.2K | 0.00% |
| Quadrature Capital Ltd | 10,249 | $42.8K | 0.00% |
| GF Fund Management Co. Ltd. | 2,215 | $9.21K | 0.00% |
| Skopos Labs, Inc. | 409 | $1.70K | 0.00% |
| Caitong International Asset Management Co., Ltd | 163 | $678 | 0.00% |
| EverSource Wealth Advisors, LLC | 114 | $474 | 0.00% |
| IFP Advisors, Inc | 60 | $249 | 0.00% |
| True Wealth Design, LLC | 52 | $217 | 0.00% |
Sold out (21)
Institutions that held Maxcyte, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ameriprise Financial Inc | 1,116,300 | $4.34M |
| Roubaix Capital, LLC | 427,515 | $1.66M |
| UBS Asset Management Americas Inc | 203,648 | $792.2K |
| Swiss National Bank | 184,400 | $717.3K |
| Algert Global LLC | 81,625 | $317.5K |
| Ensign Peak Advisors, Inc | 59,013 | $229.6K |
| Sherbrooke Park Advisers LLC | 35,287 | $137.3K |
| Janus Henderson Group PLC | 30,087 | $116.9K |
| Arizona State Retirement System | 27,093 | $105.4K |
| Verition Fund Management LLC | 21,335 | $83.0K |
| Options Solutions, LLC | 19,386 | $75.4K |
| Pictet Asset Management Holding SA | 14,535 | $56.5K |
| State of Wyoming | 12,413 | $48.3K |
| Aquatic Capital Management LLC | 12,400 | $48.2K |
| Prelude Capital Management, LLC | 10,700 | $41.6K |
| Federated Hermes, Inc. | 9,736 | $37.9K |
| Simplex Trading, LLC | 3,499 | $13.0K |
| Quadrant Capital Group LLC | 516 | $2.01K |
| Bessemer Group Inc | 300 | $1.00K |
| Lindbrook Capital, LLC | 237 | $922 |
| Capital Performance Advisors LLP | 12 | $47 |
Not filed for Q4 2024 yet (1)
Institutions that held Maxcyte, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| AJOVista, LLC | 38,707 | $150.6K |